eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
6/2015
vol. 19
 
Share:
Share:
abstract:
Review paper

Potential use of histone deacetylase inhibitors in cancer therapy

Karolina Gołąbek
,
Joanna K. Strzelczyk
,
Andrzej Wiczkowski
,
Marek Michalski

Contemp Oncol (Pozn) 2015; 19 (6): 436–440
Online publish date: 2015/05/28
View full text Get citation
 
PlumX metrics:
Epigenetics is a branch of science that focuses on mechanisms related to control and modification of expression of genetic material without any changes to its sequences. Such mechanisms include post-translational modifications of histones. It is widely known that carcinogenesis is related to hypoacetylation of genes that influence apoptosis, the cell cycle, cell signaling, the immunologic response, angiogenesis and occurrence of metastasis. Currently conducted research focuses on several strategies related to epigenetic therapy. One such strategy is based on the use of histone deacetylase inhibitors. This paper presents mechanisms through which these compounds work and a summary of their characteristics. It also includes a review of clinical tests related to histone deacetylase inhibitors, as well as their relationship with other chemotherapeutic methods. A better understanding of the involved mechanisms will provide a rational basis to improve the therapeutic outcome of available antitumor agents.
keywords:

epigenetics, histone dea cetylase, histone deacetylase inhibitor, cancer therapy

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.